These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 13244856)

  • 1. The Food and Drug Administration; our mutual responsibility.
    HOLLAND AH
    N Y State J Med; 1955 Aug; 55(16):2327-30. PubMed ID: 13244856
    [No Abstract]   [Full Text] [Related]  

  • 2. The Food and Drug Administration and the Pharmaceutical industry.
    KLUMPP TG
    J Indiana State Med Assoc; 1961 Nov; 54():1680-90. PubMed ID: 14457165
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA regulations and guidelines.
    Rothschild A
    J Parenter Sci Technol; 1990; 44(1):26-9. PubMed ID: 2313489
    [No Abstract]   [Full Text] [Related]  

  • 4. A strike against preemption.
    Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary supplements: background for dialogue between the industry and the medical profession.
    Friede AI
    Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's role in drug product recalls.
    Crawford SY
    Am J Hosp Pharm; 1991 Dec; 48(12):2595-6. PubMed ID: 1814194
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug pipeline: 2Q15.
    DeFrancesco L
    Nat Biotechnol; 2015 Aug; 33(8):795. PubMed ID: 26252129
    [No Abstract]   [Full Text] [Related]  

  • 8. Are we overregulated?
    Somberg JC
    Am J Ther; 2001; 8(1):1-2. PubMed ID: 11304650
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric Research Equity Act.
    J Natl Cancer Inst; 2004 Dec; 96(24):1810. PubMed ID: 15601636
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-label promotion.
    Somberg J
    Am J Ther; 2006; 13(5):387. PubMed ID: 16988530
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA's critical path initiative: a brief introduction.
    Coons SJ
    Clin Ther; 2009 Nov; 31(11):2572-3. PubMed ID: 20110002
    [No Abstract]   [Full Text] [Related]  

  • 12. White House addresses drug shortages.
    Traynor K
    Am J Health Syst Pharm; 2011 Dec; 68(23):2204, 2206. PubMed ID: 22095801
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the regulation of pharmaceutical drug promotion [Editorial].
    Krane NA; Sataloff RT
    Ear Nose Throat J; 2014 Dec; 93(12):486-8. PubMed ID: 25531838
    [No Abstract]   [Full Text] [Related]  

  • 14. Personal responsibility and the Food and Drug Law.
    Janssen WF
    FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
    [No Abstract]   [Full Text] [Related]  

  • 15. Senator proposes drug shortages law.
    Thompson CA
    Am J Health Syst Pharm; 2011 Mar; 68(6):461. PubMed ID: 21378289
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug shortages--Congress listens, FDA acts.
    Thompson CA
    Am J Health Syst Pharm; 2012 Jan; 69(2):90-1. PubMed ID: 22215347
    [No Abstract]   [Full Text] [Related]  

  • 17. PDUFA V goes back to basics.
    Mullard A
    Nat Rev Drug Discov; 2012 Aug; 11(8):586-8. PubMed ID: 22850772
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharma allowed to make own genetics.
    Owens J
    Nat Rev Drug Discov; 2005 Jul; 4(7):530. PubMed ID: 16075483
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: FDA oversight.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845
    [No Abstract]   [Full Text] [Related]  

  • 20. RECENT DRUG LEGISLATION IN THE UNITED STATES.
    AESCHLIMANN J
    Pharm Acta Helv; 1964; 39():193-6. PubMed ID: 14246809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.